Vingmed AS, headquartered in Norway, is a prominent player in the medical technology industry, specialising in innovative solutions for cardiovascular diagnostics. Founded in 1995, the company has established itself as a leader in developing advanced ultrasound systems and software that enhance patient care and streamline clinical workflows. With a strong presence in Europe and expanding operations globally, Vingmed AS is renowned for its unique offerings, including state-of-the-art echocardiography systems that provide unparalleled imaging quality and user-friendly interfaces. The company’s commitment to research and development has led to significant milestones, positioning it as a trusted partner in the healthcare sector. Vingmed AS continues to drive advancements in medical imaging, ensuring that healthcare professionals have the tools they need to deliver exceptional patient outcomes.
How does Vingmed AS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Vingmed AS's score of 26 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Vingmed AS, headquartered in Norway, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is identified as a current subsidiary and does not inherit emissions data from a parent organization. In terms of climate commitments, Vingmed AS has not established any documented reduction targets or initiatives, nor does it participate in recognised climate pledges such as the Science Based Targets initiative (SBTi). This lack of publicly available information suggests that Vingmed AS may still be in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability, Vingmed AS may benefit from establishing clear emissions reduction goals and participating in global climate initiatives to enhance its environmental impact and align with best practices in corporate responsibility.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Vingmed AS has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

